COMMUNIQUÉS West-GlobeNewswire

Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
17/03/2026
KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the third [...]
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
17/03/2026
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced it will [...]
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
17/03/2026
On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan- [...]
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
17/03/2026
Unique structural features of firmonertinib enhance binding and activity against EGFR mutant proteins including ex20ins mutant proteins in cell lines and NSCLC animal models Superior anti-tumor activity of ARR-002 in [...]
Caring for the Body, PLLC Launches Physician-Led Re-Think Aging Platform to Advance a New Era of Cognitive Decline Prevention and Longevity Care
17/03/2026
Asheville, NC, March 17, 2026 (GLOBE NEWSWIRE) -- Caring for the Body, PLLC – Center for Functional Medicine, a physician-led medical practice based in Asheville, North Carolina, today announced the continued expansion [...]
HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook
17/03/2026
Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion. Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year. Net income per diluted share rose to $ [...]
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
17/03/2026
Data was published in the Online Itinerary Planner for the 2026 AACR Annual Meeting, and is scheduled to be presented at the meeting on April 19th GARDEN CITY, N.Y., March 17, 2026 (GLOBE NEWSWIRE) -- Beyond Cancer, Ltd [...]
Evaxion to present new data at AACR Annual Meeting
17/03/2026
Two abstracts accepted for presentation One abstract on new additional biomarker and immunogenicity data for personalized cancer vaccine EVX-01 Another abstract on the use of Evaxion’s AI-Immunology™ platform in [...]
Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025
17/03/2026
Communiqué de mise à disposition des comptes consolidés au 31 décembre 2025. Le Groupe annonce avoir mis à la disposition du public ses comptes consolidés au 31 décembre 2025 sur le site internet du Groupe, à l’adresse [...]
Virbac : résultats annuels 2025
17/03/2026
Une marge opérationnelle 2 robuste de 16,3 %, portée par une solide croissance organique du chiffre d'affaires de 7,9 %. Dynamique 2025 solide avec un chiffre d'affaires annuel en hausse de +7,9 % à périmètre et taux de [...]
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025
17/03/2026
Public release of Virbac Consolidated Accounts at 31 December 2025. The Group released its 2025 Consolidated Accounts. The document is available on the corporate website, at corporate.virbac.com, under “Investors”, “ [...]
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
17/03/2026
Jails outpace prisons in offering MOUD, but regional disparities and limited treatment access persist across the U.S. Qualitative feedback points to need for greater reentry support, housing, care coordination, and [...]
Virbac: 2025 annual results
17/03/2026
A robust adjusted EBIT margin² of 16.3% at CERS, driven by solid organic revenue growth of 7.9% Solid 2025 dynamic with annual revenue up +7.9% at CERS; with strong momentum in key categories and countries. Volume/mix [...]
Compass Health Invites Community to “Camp Out” for Youth Behavioral Health
17/03/2026
Annual fundraiser supports programs for children, youth, and families across Northwest Washington EVERETT, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- For fifteen years, Compass Health has hosted therapeutic camps that [...]
SK pharmteco annonce le succès de l’inspection de son site de fabrication de petites molécules par la FDA, à La Porte, au Texas
17/03/2026
RANCHO CORDOVA, Californie, 17 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco a annoncé aujourd’hui l’issue favorable de l’inspection réglementaire de son site de petites molécules en Amérique du Nord, situé à La Porte, au [...]
UPDATE – Pennant Group to Participate in the 2026 Oppenheimer Annual Healthcare Conference
17/03/2026
EAGLE, Idaho, March 17, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Naturonel Launches Made-in-USA Herbal Supplements to Support Metabolic Wellness
17/03/2026
New line of plant-based dietary supplements tested for purity and potency now available to consumers nationwide. Naturonel Image PRINCETON, N.J., March 17, 2026 (GLOBE NEWSWIRE) -- Naturonel, a wellness brand focused on [...]
Personalized Keto Made Easy: How Ketoway Supports Consistent Results and Healthy Habits
17/03/2026
Ketoway Helps Users Achieve Lasting Keto Success with Personalized Meal Plans, Guided Workouts, and Transparent Customer Support NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Ketoway is a personalized keto-diet app [...]
Moleculin to Present at 38th Annual ROTH Conference
17/03/2026
– Management to participate in fireside chat presentation with Jonathan Aschoff, Senior Research Analyst at ROTH Capital Partners HOUSTON, March 17, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“ [...]

Pages